Center for Biologics Evaluation and Research (CBER)
The Center for Drug Evaluation and Research (CDER) is the part of the U.S. Food and Drug Administration (FDA) that is responsible for evaluating new drugs. It evaluates whether a particular drug meets certain standards before approving it for use by patients.
More information about Center for Biologics Evaluation and Research (CBER)
Cber,vaccines,Center for Biologics Evaluation and Research,biological products,blood,review,blood components,paper,development,guidance,Department of Health and Human Services,public health,event,medical device,review process,blood products.
CBER Offices & Divisions,CBER-Regulated Products,committees,Center for Biologics Evaluation and Research, Food and Drug Administration,health,material,biotechnology,testing,authority,monoclonal antibodies,therapeutic proteins,allergenic extracts,clinical trial,immune responses.
Interstate commerce,Silver Spring,cellular products,medical products,Food and Drug Administration,electronic submissions,Human cells,diagnostic tests,CMC Review,Clinical Review Branch,Manufacturing Review,”-796-2640,CMC Review Branch”,”301-796-2640,Clinical Review Branch”,PhD 301-796-2640 CMC Review Branch,Review Management Support Branch,-402-7332 Manufacturing Review,240-402-7314 Manufacturing Review Branch II,240-402-9220 Devices Review.
240-402-9706 Manufacturing Review Branch III,”301-796-2640,CMC Review Branch”,”301-796-2640,Review Management Support Branch”,301-796-2640 Clinical Review Branch,301-796-2640 Review Management Support Branch,Application Review Branch,blood banks,supply of blood,administration of blood,blood bags,blood bank collection machines,Blood Bank Devices,Blood Components,blood donations,blood for transfusion,Blood Products eSubmitter Program,blood substitutes,blood tests,blood transfusion,blood typing,blood vessels,CBER Document Control Center,CBER Service Fellowship,CBER Key Staff,CBER ORISE, Service,”CBER Regulated Products,Biological”,”CBER Vision & Mission,International Activities,”,CBER-Regulated,CBER-Regulated Products,CBER-regulated devices,CBER-Regulated Products: Shortages and,CBER-Regulated ProductsA PMA,CBER-Regulated ProductsAn Investigational New Drug Application,paper comments,paper submissions,address for paper submissions,address of paper,advisory committees,Allergenic Products Advisory Committee,Analgesic Drug Products Advisory Committee,Antimicrobial Drugs Advisory Committee,Laboratory of Method Development,240-402-7800 Career Development,Advanced Topics: Successful Development of Quality Cell,Career Development and Directed Training Branch,Biologics,Bureau of Biologics,Guidance for Industry and Food and Drug Administration Staff,guidance documents,authoritative guidance,Health and Human Services,efficacy of vaccines,Medical Policy & Vaccine Safety,Bovine-Derived Materials,bovine materials,adverse events,Adverse event reports,biotechnology manufacturers,biotechnology revolution,pre-clinical and clinical testing,testing methods,legal authorities,broad authority.